The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
It has been said on here before about enticing investors with what I would call close to promises by Mr A... I’m certainly not a day trader but neither leave it sitting.
I have 3 other 10k investments and they have returned so much more 35% -65%. Honestly, I had so much enthusiasm but choose to depart very very reluctantly especially after listening to all the companies news and interviews- though some of these seemed a tad too optimistic.
Ps- door has been closed and locked behind me “ wherethefoxhat”
I’ve enjoyed reading nearly 90% of comments which I must admit have kept me here until now.
TC All.
There have been so many missed opportunities for Avacta to get their testing out. Dragged on and on and my £10.5 k has been sitting here for months now. I’ve held on because I believed in A but they’ve been beaten to the post too many times.
Time to move my £10.5k on - good luck folks.
Condor Program Testing kits
:The Department of Health and Social Care has issued a policy paper covering the scaling up of coronavirus (COVID-19) testing programmes.
We are working with partners to support the delivery of the government’s agenda on COVID-19 testing.
To help scale up testing capability, the government is seeking proposals in support of reliable and accurate antibody testing that are scalable, resilient and scientifically robust.
Patented drugs on cancer drugs.
LG-310 mill dollars signup-5 mill to revive in next few months.
Pre clinical milestones to be paid re affirmers
ADC backed by ASZ- fully funded re affirmers for drug condugates-
Moderna- when they file an IND will receive funds.
Just explaining revenue streams
It’s very clear to me the Covid testing is a big thing for Avacta however the real core business is Theraputics where they are world class leaders - leaders in chemotherapy drugs development. Looking very promising with proceed of funds.
Discussing prostrate and cervical cancer.